The newly established breast cancer cell line G3S1, derived from EM-G3 breast cancer progenitors, was analyzed for functional changes related to neoplastic progression manifested by elevated invasiveness and enhanced capability to degrade gelatin. Degradation of gelatin and invasiveness of G3S1 cells was found to be dependent on the activity of matrix proteinases and actin cytoskeletal dynamics. Therefore, the expression and activity of these proteases was compared in G3S1 and EM-G3 cells. Despite enhanced capability of G3S1 cells to degrade gelatin, these cells exhibited lower levels of secreted extracellular matrix degrading proteases than parental EM-G3 cells. However, the expression of membrane-bound MT1-MMP was strongly elevated in G3S1 cells. While the degradation of gelatin was associated with invadopodia-like structures in both EM-G3 and G3S1 cells, the cytoskeletal remodeling dynamics was greatly elevated in G3S1 cells, suggesting that upregulation of MT1-MMP, together with elevation of cytoskeletal remodeling dynamics can effectively cause elevated invasiveness and enhanced matrix degrading capability in G3S1 cells.

Department of Cell Biology Faculty of Science Charles University Prague 128 43 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12025150

003      

CZ-PrNML

005      

20130218195624.0

007      

ta

008      

120816s2010 gr f 000 0#eng||

009      

AR

024    7_

$a 10.3892/ijo_00000560 $2 doi

035    __

$a (PubMed)20198326

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a gr

100    1_

$a Tolde, Ondřej. $7 _AN062495 $u Department of Cell Biology, Faculty of Science, Charles University in Prague, 128 43 Prague, Czech Republic.

245    10

$a Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP / $c O. Tolde, D. Rösel, C.T. Mierke, D. Paňková, P. Folk, P. Veselý, J. Brábek

520    9_

$a The newly established breast cancer cell line G3S1, derived from EM-G3 breast cancer progenitors, was analyzed for functional changes related to neoplastic progression manifested by elevated invasiveness and enhanced capability to degrade gelatin. Degradation of gelatin and invasiveness of G3S1 cells was found to be dependent on the activity of matrix proteinases and actin cytoskeletal dynamics. Therefore, the expression and activity of these proteases was compared in G3S1 and EM-G3 cells. Despite enhanced capability of G3S1 cells to degrade gelatin, these cells exhibited lower levels of secreted extracellular matrix degrading proteases than parental EM-G3 cells. However, the expression of membrane-bound MT1-MMP was strongly elevated in G3S1 cells. While the degradation of gelatin was associated with invadopodia-like structures in both EM-G3 and G3S1 cells, the cytoskeletal remodeling dynamics was greatly elevated in G3S1 cells, suggesting that upregulation of MT1-MMP, together with elevation of cytoskeletal remodeling dynamics can effectively cause elevated invasiveness and enhanced matrix degrading capability in G3S1 cells.

650    _2

$a aktiny $x metabolismus $7 D000199

650    _2

$a aprotinin $x farmakologie $7 D007611

650    _2

$a nádory prsu $x enzymologie $x patologie $7 D001943

650    _2

$a nádorové buněčné linie $7 D045744

650    _2

$a pohyb buněk $x účinky léků $7 D002465

650    _2

$a cytoskelet $x účinky léků $x enzymologie $x patologie $7 D003599

650    _2

$a dipeptidy $x farmakologie $7 D004151

650    _2

$a progrese nemoci $7 D018450

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a želatina $x metabolismus $7 D005780

650    _2

$a lidé $7 D006801

650    _2

$a leucin $x analogy a deriváty $x farmakologie $7 D007930

650    _2

$a mořské toxiny $x farmakologie $7 D008387

650    _2

$a matrixová metaloproteinasa 14 $x antagonisté a inhibitory $x metabolismus $7 D053511

650    _2

$a metaloproteinasy secernované do matrix $x metabolismus $7 D053505

650    _2

$a invazivní růst nádoru $7 D009361

650    _2

$a nádorové kmenové buňky $x enzymologie $x patologie $7 D014411

650    _2

$a inhibitory proteas $x farmakologie $7 D011480

650    _2

$a pseudopodia $x enzymologie $7 D011554

650    _2

$a upregulace $7 D015854

655    _2

$a srovnávací studie $7 D003160

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1#

$a Rösel, Daniel. $7 _AN062494

700    1_

$a Mierke, Claudia T

700    1_

$a Paňková, Daniela $7 xx0141214

700    1_

$a Folk, Petr, $d 1957- $7 mzk2004258361

700    1_

$a Veselý, Pavel $7 xx0110363

700    1#

$a Brábek, Jan. $7 xx0268678

773    0_

$w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 36, č. 4 (2010), s. 833-839

856    41

$u https://pubmed.ncbi.nlm.nih.gov/20198326 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m

990    __

$a 20120816 $b ABA008

991    __

$a 20130218195825 $b ABA008

999    __

$a ok $b bmc $g 947192 $s 782496

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2010 $b 36 $c 4 $d 833-839 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350

LZP    __

$a Pubmed-20120816/10/02